Home
>
National Drug Code (NDC)
>
REVIA
REVIA - 51285-275-02 - (naltrexone hydrochloride)
Drug Information of REVIA
| Product NDC: | 51285-275 |
| Proprietary Name: | REVIA |
| Non Proprietary Name: | naltrexone hydrochloride |
| Active Ingredient(s): | 50 mg/1 & nbsp; naltrexone hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of REVIA
| Product NDC: | 51285-275 |
| Labeler Name: | Teva Women's Health, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074918 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030718 |
Package Information of REVIA
| Package NDC: | 51285-275-02 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (51285-275-02) |
NDC Information of REVIA
| NDC Code | 51285-275-02 |
| Proprietary Name | REVIA |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (51285-275-02) |
| Product NDC | 51285-275 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | naltrexone hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20030718 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Women's Health, Inc |
| Substance Name | NALTREXONE HYDROCHLORIDE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
